tamoxifen moa | Tamoxifen - StatPearls

Keyword	CPC	PCC	Volume	Score	Length of keyword
tamoxifen moa	0.42	0.9	5069	85	13
tamoxifen	0.74	0.2	8445	37	9
moa	1.58	0.9	9164	36	3

Keyword	CPC	PCC	Volume	Score
tamoxifen moa	1.54	1	3021	36
tamoxifen moa nolvadexolf	0.87	0.4	4793	61
tamoxifen vs raloxifene moa	1.07	0.3	6492	65
raloxifene vs tamoxifen agonist	0.46	0.1	6295	73
tamoxifen vs raloxifene mechanism of action	0.11	0.9	6964	50
difference between tamoxifen and raloxifene	0.33	0.3	8581	97
tamoxifen vs raloxifene breast cancer	0.5	0.6	5324	28
raloxifene vs tamoxifen side effects	1.6	0.5	4204	55
tamoxifen vs raloxifene usmle	1.33	0.8	1505	80
tamoxifen vs no tamoxifen	1.12	0.3	394	45

Search Results related to tamoxifen moa on Search Engine

Tamoxifen - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK532905/

WEBApr 10, 2023 · Objectives: Explain the mechanism of action of tamoxifen. Identify the approved indications of tamoxifen, and cite some of the non-approved indications as well. Review the adverse event profile of tamoxifen therapy.

DA: 13 PA: 63 MOZ Rank: 22

Tamoxifen: Uses, Interactions, Mechanism of Action | DrugBank …
drugbank.com

https://go.drugbank.com/drugs/DB00675

WEBDec 30, 2015 · Tamoxifen is a non-steroidal antiestrogen used to treat estrogen receptor positive breast cancers as well as prevent the incidence of breast cancer in high risk populations. 1,15,16 Tamoxifen is used alone or as an adjuvant in these treatments. 15,16 Tamoxifen may no longer be the preferred treatment for these types of cancers as …

DA: 33 PA: 96 MOZ Rank: 23

Tamoxifen - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Tamoxifen

WEBTamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. It is also being studied for other types of cancer. It has been used for Albright syndrome. Tamoxifen is typically taken daily by mouth for five years for breast cancer.

DA: 13 PA: 63 MOZ Rank: 66

The mechanism of tamoxifen in breast cancer prevention - PMC
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300587/

WEBMay 29, 2001 · Tamoxifen (TAM) is known to have a dual mechanism of action: (1) to compete with 17β-estradiol (E 2) at the receptor site and to block the promotional role of E 2 in breast cancer; and (2) to bind DNA after metabolic …

DA: 10 PA: 4 MOZ Rank: 26

TAMOXIFEN - Pharmaceuticals - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK304326/

WEBFor reduction in the incidence of breast cancer in women at high risk, the recommended dosage of tamoxifen is 20 mg daily given for 5 years. For the treatment of advanced (metastatic) breast cancer in men, the usual dosage of tamoxifen is 20–40 mg daily.

DA: 89 PA: 28 MOZ Rank: 68

Frontiers | Progress in the Understanding of the Mechanism of Tamoxifen
frontiersin.org

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.592912/full

WEBDec 8, 2020 · Tamoxifen is a drug commonly used in the treatment of breast cancer, especially for postmenopausal patients. However, its efficacy is limited by the development of drug resistance. Downregulation of estrogen receptor alpha (ERα) is an important mechanism of tamoxifen resistance.

DA: 95 PA: 37 MOZ Rank: 80

Tamoxifen: Mechanism of Action - Medscape
medscape.com

https://decisionpoint.medscape.com/oncology/viewarticle/917158

WEBDec 6, 2019 · Tamoxifen: Mechanism of Action. Jose P. Leone, MD · Dana-Farber Cancer Institute. Disclosures. December 06, 2019. 0. This transcript has been edited for clarity. Tamoxifen in breast cancer is a...

DA: 31 PA: 66 MOZ Rank: 59

Aromatase Inhibitors in Breast Cancer | New England Journal of Medicine
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMra023246

WEBJun 12, 2003 · Tamoxifen reduces bone demineralization through its agonist effect, at least in postmenopausal women, 20,21 whereas aromatase inhibitors may enhance this process by lowering circulating estrogen...

DA: 15 PA: 81 MOZ Rank: 22

Tamoxifen: Dosage, Mechanism/Onset of Action, Half-Life
medicine.com

https://www.medicine.com/drug/tamoxifen/hcp

WEBFeb 17, 2020 · Mechanism of Action. Tamoxifen is a selective estrogen receptor modulator (SERM) that competitively binds to estrogen receptors on tumors and other tissue targets, producing a nuclear complex that decreases DNA synthesis and inhibits estrogen effects; nonsteroidal agent with potent antiestrogenic properties which compete with estrogen for ...

DA: 49 PA: 26 MOZ Rank: 96

The mechanism of tamoxifen in breast cancer prevention
biomedcentral.com

https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr404

WEBMay 31, 2001 · Tamoxifen (TAM) is known to have a dual mechanism of action: (1) to compete with 17β-estradiol (E 2) at the receptor site and to block the promotional role of E 2 in breast cancer; and (2) to bind DNA after metabolic …

DA: 90 PA: 34 MOZ Rank: 71